association

Full identifier: http://purl.org/np/RARbESp1UemPmDS8FfAzLb5SSItb09zXCF9NyizzthFiY#association

Assigned to 1 class:

Minted in Nanopublication

 RARbESp1Ue comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RARbESp1Ue... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-27T21:19:11.106+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RARbESp1Ue... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RARbESp1Ue... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RARbESp1Ue... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
paroxetine capsules are indicated for the treatment of moderate to severe vasomotor symptoms vms associated with menopause limitation of use paroxetine capsules are not indicated for the treatment of any psychiatric condition paroxetine capsules contain a lower dose of paroxetine than that used to treat depression obsessive compulsive disorder panic disorder generalized anxiety disorder social anxiety disorder and post traumatic stress disorder the safety and efficacy of this lower dose of paroxetine in paroxetine capsules have not been established for any psychiatric condition patients who require paroxetine for treatment of a psychiatric condition should discontinue paroxetine capsules and initiate a paroxetine containing medication that is indicated for such use paroxetine is a selective serotonin reuptake inhibitor ssri indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause vms 1 limitation of use 1
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-27T19:19:11.106Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)